The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...

The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic ...

New national hepatitis elimination profiles reveal policy and implementation gaps in reaching global viral hepatitis elimination targets.

New report highlights progress and persistent gaps in global viral hepatitis elimination, underscoring need to expand testing ...

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection ...

Please provide your email address to receive an email when new articles are posted on . Currently, more than 300 million people are diagnosed with hepatitis around the world, according to the World ...

The chronic hepatitis D market is expected to grow steadily through 2034, supported by a small but advancing pipeline targeting a long-standing unmet need, according to research from DelveInsight.

CAGAYAN DE ORO CITY (PIA) — In observance of Liver Cancer and Viral Hepatitis Awareness Month this January, the Philippine ...

Since the Centers for Disease Control and Prevention began in 1991 recommending the vaccine for all children at birth, acute ...

Understanding what hepatitis C is, how it spreads and how it is treated can replace fear with clarity.